by Yi-Chiao Teng
BNCT clinical development in Mainland China is progressing under the regulatory supervision of the National Medical Products Administration (NMPA) and through specialized medical policy frameworks.
China has rapidly expanded accelerator-based BNCT development, with several centers entering early clinical implementation.
Clinical implementation currently follows two main pathways:
- Special medical access programs, allowing earlier access to innovative medical technologies.
- Registry-verified clinical trials, conducted at selected medical centers under national regulatory oversight.
The centers below represent locations with currently identifiable BNCT clinical activity.
International Patient Access
Panboron (Hainan) BNCT Hospital
📍Hainan, Mainland China
Panboron (Hainan) BNCT Hospital is located in the Bo’ao Lecheng International Medical Tourism Pilot Zone.
The hospital provides BNCT-related consultation services and clinical access pathways for both domestic and international patients.
Contact:
🌐 Official website: https://www.panboron.com/en
☎ Service hotline: +86-898-36863666📱 Official WeChat (Scan the QR code below for consultation and medical information.)
Registry-Verified BNCT Clinical Trial Centers
BNCT Center, Xiamen Humanity Hospital
📍 Xiamen, Fujian, Mainland China
The BNCT Center at Xiamen Humanity Hospital is a specialized facility dedicated to tumor treatment, employing accelerator-based BNCT technology —NeuPEXTM System— developed by Neuboron Medical Group. The center integrates clinical research, scientific training, and medical services.
- Clinical status: Registered early-phase clinical trials (ongoing)
- Clinical scope: Trial-specific oncology indications (e.g., recurrent or refractory malignancies)
- International patient access: To be confirmed via official hospital channels
🔗 Clinical trial registry (publicly verifiable; ongoing)
- ChiCTR2400088140
- ChiCTR2400082903
This center has accumulated clinical experience within the scope of its registered studies.
BNCT Center, Dongguan People’s Hospital
📍 Dongguan, Guangdong, Mainland China
- Clinical status: Registered clinical study (patient treatment initiated)
- Clinical scope: Hospital-based clinical implementation under regulated protocols
- International patient access: Not specified in registry
🔗 Clinical trial registry (publicly verifiable; ongoing)
- ChiCTR2500104608
BNCT Center, Qilu Hospital of Shandong University
📍 Qingdao, Shandong, Mainland China
- Clinical status: Registered clinical study (ongoing; patient recruitment active)
- Clinical scope: Early-phase BNCT clinical investigation under national regulatory oversight
- International patient access: Domestic patients only
🔗 Clinical trial registry (publicly verifiable; ongoing)
- CTR20253317
Clinical BNCT Landscape in Mainland China
As of 2026, BNCT clinical activity in Mainland China remains in an early clinical implementation phase, primarily conducted through registry-based clinical studies and selected medical programs.
Several additional BNCT centers are currently under construction or in planning nationwide. The centers listed on this page represent locations with publicly verifiable clinical activity.
Information for Patients and Families
BNCT is a specialized treatment that is typically offered through:
- clinical trials
- limited clinical programs
- specialized medical access frameworks
Eligibility varies depending on disease type and clinical protocol.
Patients are encouraged to consult their physicians and contact the relevant medical centers for further information.
Inclusion Statement
Centers listed on this page are included based on publicly accessible clinical trial registrations or documented clinical programs.
Projects under construction, in planning stages, or lacking publicly verifiable clinical activity are not included.